Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Caces DB"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Clinical Oncology; 1/20/2012, Vol. 30 Issue 3, pe24-6, 1p
Autor:
Niemann CU; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: carsten.utoft.niemann@regionh.dk., Munir T; St James's Hospital, Leeds, UK., Moreno C; Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Owen C; Tom Baker Cancer Centre, Calgary, AB, Canada., Follows GA; Addenbrookes Hospital, Cambridge, UK., Benjamini O; Sheba Medical Center, Ramat Gan, Israel., Janssens A; UZ Leuven Gasthuisberg, Leuven, Belgium., Levin MD; Albert Schweitzer Hospital, Dordrecht, Netherlands., Robak T; Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland., Simkovic M; 4th Department of Internal Medicine-Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Králové, Czech Republic., Voloshin S; Russian Scientific and Research Institute of Hematology and Transfusiology, St Petersburg, Russia., Vorobyev V; SP Botkin Moscow City Clinical Hospital, Moscow, Russia., Yagci M; Gazi Universitesi Tip Fakultesi, Ankara, Türkiye., Ysebaert L; Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., Qi K; Janssen Research & Development, Titusville, NJ, USA., Qi Q; Janssen Research & Development, Raritan, NJ, USA., Sinet P; Janssen Research & Development, Bridgewater, NJ, USA., Parisi L; Janssen Research & Development, Raritan, NJ, USA., Srinivasan S; Oncology Translational Research, Janssen Research & Development, Lower Gwynedd Township, PA, USA., Schuier N; Janssen Research & Development, Raritan, NJ, USA., Baeten K; Janssen Research & Development, Beerse, Belgium., Howes A; Janssen Research & Development, High Wycombe, UK., Caces DB; Janssen Research & Development, Raritan, NJ, USA., Kater AP; Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, Netherlands.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2023 Dec; Vol. 24 (12), pp. 1423-1433. Date of Electronic Publication: 2023 Nov 06.
Autor:
Nastoupil LJ; Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Hess G; Hematology Department, Johannes Gutenberg-Universität Mainz, Mainz, Germany., Pavlovsky MA; Department of Hematology, Fundaleu, Buenos Aires, Argentina., Danielewicz I; Department of Clinical Oncology, Maritime Hospital in Gdynia, Gdynia, Poland., Freeman J; Northern Haematology and Oncology Arm, Sydney Adventist Hospital, Sydney, NSW, Australia., García-Sancho AM; Department of Hematology, Hospital Universitario de Salamanca, Centro de Investigación Biomédica en Red Cáncer, Centro de Investigación del Cáncer de Salamanca-Instituto Universitario de Biología Molecular y Celular del Cáncer, Salamanca, Spain., Glazunova V; SP Botkin City Clinical Hospital, Moscow, Russia., Grigg A; Department of Clinical Haematology, Austin Hospital, Melbourne, VIC, Australia., Hou JZ; University of Pittsburgh Medical Center, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA., Janssens A; Department of Hematology, Universitair Ziekenhuis Leuven, Leuven, Belgium., Kim SJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Masliak Z; Institute of Blood Pathology and Transfusion Medicine, Lviv, Ukraine., McKay P; The Beatson West of Scotland Cancer Centre, Glasgow, Scotland., Merli F; Hematology, Azienda Unità Sanitaria Locale - Istituti di Ricovero e Cura a Carattere Scientifico di Reggio Emilia, Reggio Emilia, Italy., Munakata W; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan., Nagai H; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan., Özcan M; Department of Hematology, Ankara University School of Medicine, Ankara, Turkey., Preis M; Institute of Hematology, Lady Davis Carmel Medical Center, Haifa, Israel., Wang T; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Rowe M; Janssen Research & Development, High Wycombe, United Kingdom., Tamegnon M; Janssen Research & Development, Raritan, NJ., Qin R; Janssen Research & Development, Raritan, NJ., Henninger T; Janssen Research & Development, Raritan, NJ., Curtis M; Janssen Research & Development, High Wycombe, United Kingdom., Caces DB; Janssen Research & Development, Raritan, NJ., Thieblemont C; Hemato-Oncology Department, Hôpital Saint-Louis, Paris, France., Salles G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Publikováno v:
Blood advances [Blood Adv] 2023 Nov 28; Vol. 7 (22), pp. 7141-7150.
Autor:
Munir T; St James's Hospital, Leeds, United Kingdom., Moreno C; Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Josep Carreras Research Leukaemia Research Institute, Barcelona, Spain., Owen C; Tom Baker Cancer Centre, Calgary, Canada., Follows G; Addenbrookes Hospital, Cambridge, United Kingdom., Benjamini O; Sheba Medical Center, Ramat Gan, Israel., Janssens A; UZ Leuven Gasthuisberg, Leuven, Belgium., Levin MD; Albert Schweitzer Hospital, Dordrecht, the Netherlands., Osterborg A; Karolinska University Hospital, Stockholm, Sweden., Robak T; Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland., Simkovic M; University Hospital Hradec Kralove, Hradec Kralove, Czech Republic., Stevens D; Norton Cancer Institute, Louisville, KY., Voloshin S; Russian Scientific and Research Institute of Hematology and Transfusiology, St Petersburg, Russia., Vorobyev V; S.P. Botkin Moscow City Clinical Hospital, Moscow, Russia., Yagci M; Gazi Universitesi Tip Fakultesi, Ankara, Turkey., Ysebaert L; Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., Qi K; Janssen Research & Development, Titusville, NJ., Qi Q; Janssen Research & Development, Raritan, NJ., Parisi L; Janssen Research & Development, Raritan, NJ., Srinivasan S; Oncology Translational Research, Janssen Research & Development, Lower Gwynedd Township, PA., Schuier N; Janssen Research & Development, Düsseldorf, Germany., Baeten K; Janssen Research & Development, Beerse, Belgium., Howes A; Janssen Research & Development, High Wycombe, United Kingdom., Caces DB; Janssen Research & Development, Raritan, NJ., Niemann CU; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Kater AP; Amsterdam Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jul 20; Vol. 41 (21), pp. 3689-3699. Date of Electronic Publication: 2023 Jun 06.
Fixed-Duration Ibrutinib-Venetoclax in Patients with Chronic Lymphocytic Leukemia and Comorbidities.
Autor:
Kater AP; Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, on behalf of the HOVON CLL Working Group, Amsterdam., Owen C; Tom Baker Cancer Centre, Calgary, Alberta, Canada., Moreno C; Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona., Follows G; Addenbrooke's Hospital, Cambridge, UK., Munir T; St James's Hospital, Leeds, UK., Levin MD; Albert Schweitzer Hospital, Dordrecht, Netherlands., Benjamini O; Sheba Medical Center, Ramat Gan, Israel., Janssens A; Universitaire Ziekenhuizen Leuven, Leuven, Belgium., Osterborg A; Karolinska University Hospital, Stockholm., Robak T; Medical University of Łódź, Copernicus Memorial Hospital, Łódź, Poland., Simkovic M; University Hospital Hradec Králové, Hradec Králové, Czech Republic., Stevens D; Norton Cancer Institute, Louisville, KY., Voloshin S; Russian Scientific Research Institute of Hematology and Transfusiology, St. Petersburg, Russia., Vorobyev V; S.P. Botkin Moscow City Clinical Hospital, Moscow., Ysebaert L; Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Qin R; Janssen Research & Development, Raritan, NJ., Steele AJ; Janssen Research & Development, San Diego, CA., Schuier N; Janssen Research & Development, Düsseldorf, Germany., Baeten K; Janssen Research & Development, Beerse, Belgium., Caces DB; Janssen Research & Development, Raritan, NJ., Niemann CU; Rigshospitalet Copenhagen University Hospital, Copenhagen.
Publikováno v:
NEJM evidence [NEJM Evid] 2022 Jul; Vol. 1 (7), pp. EVIDoa2200006. Date of Electronic Publication: 2022 May 13.
Autor:
Ollberding NJ; 1Division of Biostatistics and Epidemiology,Cincinnati Children's Hospital Medical Center,Cincinnati,OH,USA., Aschebrook-Kilfoy B; 2Department of Health Studies,University of Chicago,5841 South Maryland Avenue,MC 2007,Chicago,IL 60637,USA., Caces DB; 3Division of Hematology/Oncology,Department of Medicine,University of Chicago,Chicago,IL,USA., Smith SM; 3Division of Hematology/Oncology,Department of Medicine,University of Chicago,Chicago,IL,USA., Weisenburger DD; 4Department of Pathology and Microbiology,University of Nebraska Medical Center,Omaha,NE,USA., Chiu BC; 2Department of Health Studies,University of Chicago,5841 South Maryland Avenue,MC 2007,Chicago,IL 60637,USA.
Publikováno v:
Public health nutrition [Public Health Nutr] 2014 Jul; Vol. 17 (7), pp. 1531-7. Date of Electronic Publication: 2013 May 09.
Autor:
Nabhan C; Section of Hematology and Oncology, Department of Medicine., Ollberding NJ, Villines D, Chiu BC, Caces DB, Valdez TV, Ghielmini M, Hsu Schmitz SF, Smith SM
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2014 Jun; Vol. 55 (6), pp. 1288-94. Date of Electronic Publication: 2013 Nov 01.
Autor:
Ollberding NJ; Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center , Cincinnati, OH , USA., Aschebrook-Kilfoy B, Caces DB, Smith SM, Weisenburger DD, Chiu BC
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2013 Dec; Vol. 54 (12), pp. 2613-9. Date of Electronic Publication: 2013 Apr 30.
Autor:
Ollberding NJ; Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Health Studies, University of Chicago, Chicago, IL, USA., Evens AM, Aschebrook-Kilfoy B, Caces DB, Weisenburger DD, Smith SM, Chiu BC
Publikováno v:
British journal of haematology [Br J Haematol] 2013 Nov; Vol. 163 (3), pp. 352-6. Date of Electronic Publication: 2013 Aug 02.